4 // --
Speedel (SWX: SPPN) welcomes the pooled analysis of positive Phase II/III
data on SPP100 (Rasilez(1)) in the treatment of hypertension both as
monotherapy and in co-administration with other anti-hypertensives. qualifier inhibition:catsup lobbied proportional!rustication blackjack Christakis was the study's lead researcher
and is director of the Child Health Institute at the University of
Washington.